Biogen Idec Inc BIIB:NASDAQ (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
326.88 6.76   2.11%991,226983.5K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Market is closed. As of 03:59 PM ET 9/16/2014

Latest News Headlines for Biogen Idec Inc

Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 15, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Amgen Inc. (NASDAQ: AMGN), Biogen Idec Inc. (NASDAQ: BIIB), Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), Covidien plc (NYSE: COV) and Shire plc (NASDAQ: SHPG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at:

Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp.

Editor Note: For more information about this release, please scroll to bottom. LONDON, September 15, 2014 /PRNewswire/ -- On Friday, September 12, 2014, the NASDAQ Composite ended at 4,567.60, down 0.53%, the Dow Jones Industrial Average finished the day 0.36% lower at 16,987.51, and the S&P 500 closed at 1,985.54, down 0.60%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 736.69, down 0.69%, while the index has advanced 2.86% in the last one month. Investor-Edge has initiated coverage on the following equities: Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE), InterMune Inc. (NASDAQ: ITMN), Biogen Idec Inc. (NASDAQ: BIIB), Hologic Inc. (NASDAQ: HOLX), and CareFusion Corporation (NYSE: CFN). Free research on these five companies can be accessed at:

Critical Alerts For U.S. Bancorp, Nuverra Environmental Solutions, Biogen, Deere and Philip Morris International Released By InvestorsObserver

CHICAGO, Sept. 12, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for USB, NES, BIIB, DE and PM. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You may have to copy this link into your browser then press the [ENTER] key.)

View more recent headlines

Latest Annual and Quarterly SEC Filings

More Filings

This report contains detailed information about the company's business finances and management.


Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company's products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN. In September 2011, the Company acquired from the Dompe Group the noncontrolling interests in its joint venture sales affiliates in Italy and Switzerland. In April 2013, Elan Corporation, plc closed the TYSABRI (natalizumab) Collaboration Transaction with Biogen Idec.


collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open319.42
Previous Close320.12
Day High328.75
Day Low318.69
52 Week High3/19/2014 | 358.89
52 Week Low10/9/2013 | 221.07
% Off 52 Week High-8.92%
% Off 52 Week Low47.86%
Beta (5 Yr)1.2
Volatility Avg9/15/2014 | 36.51
10-Day Avg. Volume983,508
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | 9.00
P/E Ratio6/30/2014 | 35.9
Market CapLarge Cap | 77.2B
Shares Outstanding236.15M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short3.18M
Short Ratio4.0
Short % of Float1.35%
As of 8/29/2014

Peers Information HelpBIIB Biogen Idec Inc vs. Peers

Biogen Idec Inc
Johnson & Johnson
Pfizer Inc.
Merck & Co., Inc.
AbbVie Inc
Biogen Idec Inc
Johnson & Johnson
Pfizer Inc.
Merck & Co., Inc.
AbbVie Inc
Biogen Idec Inc
Johnson & Johnson
Pfizer Inc.
Merck & Co., Inc.
AbbVie Inc
Compare these stocks